Company

Biogen

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 8, 2026 · OBSERVATIONAL STUDY

A Long-Term Study of Patient-Reported Changes in Postpartum Depression Symptoms in People Starting Zuranolone

ClinicalTrials.gov

This is a registry record for a planned observational study with no results reported; it describes study design and procedures only, not outcomes or efficacy.

PreliminaryNCT07398469 Biogen Zuranolone

Reported

Planned sample size300

Primary outcome measureChange from baseline in Edinburgh Postnatal…

Assessment timepointsBaseline (Day 0), Day 3, Day 15, Day 45, Da…

SEP 8, 2026 · OBSERVATIONAL STUDY

A Study to Learn More About How Zuranolone Affects Postpartum Depression Symptoms in Participants Who Took it Within 1 Year After The End of Their Pregnancy

ClinicalTrials.gov

This is a registry record for a prospective observational study with no results reported; recruitment is complete but outcome data have not yet been published or posted.

PreliminaryNCT07047820 Depression, Postpartum Biogen

Reported

Planned enrollment305

Primary outcome measureChange from Baseline in Edinburgh Postnatal…

Secondary outcome measuresEPDS change at Day 3, Day 45, and Day 90; b…